Visual and anatomical outcomes of spironolactone therapy in patients with chronic central serous chorioretinopathy

Purpose: To evaluate the effect of spironolactone on chronic central serous chorioretinopathy (CSC). Methods: In this prospective interventional case series, patients with chronic cSc were treated with spironolactone (25 mg daily) for at least 6 weeks. If the subretinal fluid (SRF) had not completel...

Full description

Bibliographic Details
Main Authors: Khalil Ghasemi Falavarjani, Anahita Amirsardari, Abbas Habibi, Acieh Eshaghi, Shohreh Bakhti, Kaveh Abri Aghdam
Format: Article
Language:English
Published: Knowledge E 2017-01-01
Series:Journal of Ophthalmic & Vision Research
Subjects:
Online Access:http://www.jovr.org/article.asp?issn=2008-322X;year=2017;volume=12;issue=3;spage=281;epage=289;aulast=Falavarjani